Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Furlan

Showing results (191-200 of 225) with videos related to

Pageof 23
Sort By:
Annals of Neurology|December 10, 2013
Allogeneic hematopoietic stem cell transplantation for neuromyelitis opticaRaffaella Greco, Attilio Bondanza, Luca Vago, et al.
Genes|February 25, 2022
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple SclerosisEttore Dolcetti, Antonio Bruno, Federica Azzolini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 5, 2019
Obesity worsens central inflammation and disability in multiple sclerosisMario Stampanoni Bassi, Ennio Iezzi, Fabio Buttari, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 12, 2015
Comparative Neuroregenerative Effects of C-Phycocyanin and IFN-Beta in a Model of Multiple Sclerosis in MiceGiselle Pentón-Rol, Nielsen Lagumersindez-Denis, Luca Muzio, et al.
International Journal of Molecular Sciences|May 25, 2024
Interaction between miR-142-3p and <i>BDNF</i> Val/Met Polymorphism Regulates Multiple Sclerosis SeverityEttore Dolcetti, Alessandra Musella, Sara Balletta, et al.
Current Neuropharmacology|April 6, 2023
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple SclerosisFrancesca De Vito, Sara Balletta, Silvia Caioli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 30, 2021
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort studyMaria Pia Sormani, Irene Schiavetti, Doriana Landi, et al.
Frontiers in Molecular Neuroscience|August 22, 2024
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosisLuana Gilio, Diego Fresegna, Mario Stampanoni Bassi, et al.
Neurobiology of Disease|July 14, 2022
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosisLuana Gilio, Diego Fresegna, Antonietta Gentile, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 25, 2021
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depressionMaria S Simon, Carmen Schiweck, Gara Arteaga-Henríquez, et al.
Pageof 23

Showing results (191-200 of 225) with videos related to

Sort By:
Pageof 23
Annals of Neurology|December 10, 2013
Allogeneic hematopoietic stem cell transplantation for neuromyelitis opticaRaffaella Greco, Attilio Bondanza, Luca Vago, et al.
Genes|February 25, 2022
The BDNF Val66Met Polymorphism (rs6265) Modulates Inflammation and Neurodegeneration in the Early Phases of Multiple SclerosisEttore Dolcetti, Antonio Bruno, Federica Azzolini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 5, 2019
Obesity worsens central inflammation and disability in multiple sclerosisMario Stampanoni Bassi, Ennio Iezzi, Fabio Buttari, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 12, 2015
Comparative Neuroregenerative Effects of C-Phycocyanin and IFN-Beta in a Model of Multiple Sclerosis in MiceGiselle Pentón-Rol, Nielsen Lagumersindez-Denis, Luca Muzio, et al.
International Journal of Molecular Sciences|May 25, 2024
Interaction between miR-142-3p and <i>BDNF</i> Val/Met Polymorphism Regulates Multiple Sclerosis SeverityEttore Dolcetti, Alessandra Musella, Sara Balletta, et al.
Current Neuropharmacology|April 6, 2023
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple SclerosisFrancesca De Vito, Sara Balletta, Silvia Caioli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 30, 2021
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort studyMaria Pia Sormani, Irene Schiavetti, Doriana Landi, et al.
Frontiers in Molecular Neuroscience|August 22, 2024
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosisLuana Gilio, Diego Fresegna, Mario Stampanoni Bassi, et al.
Neurobiology of Disease|July 14, 2022
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosisLuana Gilio, Diego Fresegna, Antonietta Gentile, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 25, 2021
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depressionMaria S Simon, Carmen Schiweck, Gara Arteaga-Henríquez, et al.
Pageof 23